Evidence map›Paper›PMID 31535058›Full record

ArticleNeurobiology of pain (Cambridge, Mass.)

Monosodium iodoacetate-induced monoarthritis develops differently in knee versus ankle joint in rats.

Kristina Ängeby Möller, Stephanie Klein, Frank Seeliger, Anja Finn, Carina Stenfors, Camilla I Svensson

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of pain (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Uncoupling the CRMP2-CaThe journal of pain · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Uncoupling the CRMP2-CabioRxiv : the preprint server for biology · 2024
    Article
  8. Targeting Some Key Metalloproteinases by Nano-Naringenin andPharmaceuticals (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristina Ängeby MöllerAstraZeneca R&D Södertälje, CNSP iMed Science, SE-151 85 Södertälje, Sweden.
Stephanie KleinAstraZeneca R&D Södertälje, Safety Pharmacology, SE-151 85 Södertälje, Sweden.
Frank SeeligerAstraZeneca R&D Södertälje, Safety Pharmacology, SE-151 85 Södertälje, Sweden.
Anja FinnAstraZeneca R&D Södertälje, CNSP iMed Science, SE-151 85 Södertälje, Sweden.
Carina StenforsAstraZeneca R&D Södertälje, CNSP iMed Science, SE-151 85 Södertälje, Sweden.
Camilla I SvenssonDepartment of Physiology and Pharmacology, Karolinska Institutet, SE-171 76 Stockholm, Sweden.
AstraZeneca (Sweden) · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDisability and movement-related pain are major symptoms of joint disease, motivating the development of methods to quantify motor behaviour in rodent joint pain models. We compared effects on behaviour, assessed the levels of biochemical mediators and made a detailed histopathological evaluation after induction of rat monoiodoacetate (MIA) monoarthritis into the ankle or knee joint.

designTwenty-seven male Lewis rats were used. Before and up to 28 days after induction, they were tested for weight bearing during walking (dynamic), and standing (static), and for mechanical sensitivity. At termination synovial fluid was taken from ankle and/or knee joints for analysis of monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), macrophage inflammatory protein 3 alpha (MIP-3α), keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) and L(+)-lactate, and from separate rats joints were collected for histopathological assessment.

resultsMIA ankle joint injection gave a marked reduction of dynamic weight bearing during the first days, not seen in rats with knee joint injection. At three weeks, it was decreased in the group with knee injection, but not in those with ankle injection. However, the different injection sites caused similar reductions in static weight bearing during the early phase, which was normalized in the group with ankle injection but continued and was strengthened with time in the knee injected group. Histopathological assessment, biochemical mediators and joint swelling confirmed the disparate profiles.

conclusionsThis work shows that ankle versus knee joint injection of MIA resulted in different profiles in rats, which may mirror what has been found in human patients with osteoarthritis.

Indexed as

ArthritisGait analysisInflammationPainPawPrintWeight bearing

Identifiers

PMID31535058
PMCPMC6744596
OpenAlexW2971951791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.